Immune system-related soluble mediators and COVID-19: basic mechanisms and clinical perspectives.

COVID-19 SARS-CoV-2 Soluble immune checkpoints Soluble immune mediator

Journal

Cell communication and signaling : CCS
ISSN: 1478-811X
Titre abrégé: Cell Commun Signal
Pays: England
ID NLM: 101170464

Informations de publication

Date de publication:
29 08 2022
Historique:
received: 15 06 2022
accepted: 02 08 2022
entrez: 29 8 2022
pubmed: 30 8 2022
medline: 1 9 2022
Statut: epublish

Résumé

During SARS-CoV-2 infection, an effective immune response provides the first line of defense; however, excessive inflammatory innate immunity and impaired adaptive immunity may harm tissues. Soluble immune mediators are involved in the dynamic interaction of ligands with membrane-bound receptors to maintain and restore health after pathological events. In some cases, the dysregulation of their expression can lead to disease pathology. In this literature review, we described current knowledge of the basic features of soluble immune mediators and their dysregulation during SARS-CoV-2 infections and highlighted their contribution to disease severity and mortality. Video Abstract.

Identifiants

pubmed: 36038915
doi: 10.1186/s12964-022-00948-7
pii: 10.1186/s12964-022-00948-7
pmc: PMC9421625
doi:

Types de publication

Journal Article Review Video-Audio Media Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

131

Informations de copyright

© 2022. The Author(s).

Références

Sci Rep. 2016 Dec 19;6:39481
pubmed: 27991579
Mol Ther Methods Clin Dev. 2022 Sep 8;26:266-278
pubmed: 35818571
Signal Transduct Target Ther. 2020 Sep 7;5(1):192
pubmed: 32895366
Front Immunol. 2020 Nov 19;11:587460
pubmed: 33329567
J Clin Med Res. 2018 Sep;10(9):700-706
pubmed: 30116440
Br J Cancer. 1995 Aug;72(2):452-5
pubmed: 7640231
Mol Diagn Ther. 2020 Oct;24(5):517-521
pubmed: 32613288
Sci Rep. 2018 Feb 8;8(1):2603
pubmed: 29422518
Clin Immunol. 2020 Sep;218:108515
pubmed: 32619646
Int J Biol Sci. 2012;8(9):1237-47
pubmed: 23136552
Blood. 2020 Sep 3;136(10):1169-1179
pubmed: 32597954
Clin Chim Acta. 2020 Oct;509:280-287
pubmed: 32531256
PLoS One. 2015 Mar 30;10(3):e0122073
pubmed: 25823004
PLoS One. 2021 Jul 2;16(7):e0254167
pubmed: 34214123
Gene Rep. 2021 Jun;23:101140
pubmed: 33869895
Int Immunopharmacol. 2021 Oct;99:107935
pubmed: 34304000
Biochim Biophys Acta. 2011 May;1813(5):878-88
pubmed: 21296109
Sci Rep. 2021 Oct 7;11(1):19979
pubmed: 34620968
J Biol Chem. 2015 Oct 23;290(43):26059-71
pubmed: 26359498
Int J Mol Sci. 2021 Aug 17;22(16):
pubmed: 34445556
Immunity. 1999 Dec;11(6):783-93
pubmed: 10626900
Biomed Pharmacother. 2020 Dec;132:110859
pubmed: 33120236
Front Immunol. 2021 Apr 22;12:592727
pubmed: 33968010
Lancet Haematol. 2020 Aug;7(8):e575-e582
pubmed: 32619411
Front Immunol. 2021 Jun 07;12:695242
pubmed: 34163490
Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):2455-2460
pubmed: 29463725
Front Immunol. 2016 Sep 19;7:366
pubmed: 27698656
J Leukoc Biol. 2009 Sep;86(3):505-12
pubmed: 19477910
J Med Virol. 2021 Oct;93(10):5908-5916
pubmed: 34138483
J Exp Med. 2000 Oct 2;192(7):1027-34
pubmed: 11015443
J Allergy Clin Immunol. 2021 Jan;147(1):92-98
pubmed: 32971109
Diagnostics (Basel). 2022 Apr 01;12(4):
pubmed: 35453934
J Heart Lung Transplant. 2007 Jul;26(7):675-80
pubmed: 17613396
Clin Transl Med. 2021 Oct;11(10):e573
pubmed: 34709745
Life Sci. 2021 Jul 15;277:119634
pubmed: 34015287
Rev Med Virol. 2021 Sep;31(5):1-12
pubmed: 33426683
Nat Med. 2021 Oct;27(10):1752-1760
pubmed: 34480127
Int J Infect Dis. 2021 Apr;105:522-524
pubmed: 33711520
J Reprod Immunol. 2021 Jun;145:103317
pubmed: 33813342
Cancers (Basel). 2021 Jun 17;13(12):
pubmed: 34204509
Scand J Immunol. 2005 Apr;61(4):347-56
pubmed: 15853918
J Clin Med. 2021 Oct 24;10(21):
pubmed: 34768433
Am J Respir Crit Care Med. 2015 Apr 1;191(7):804-19
pubmed: 25664391
Front Immunol. 2016 Aug 15;7:311
pubmed: 27574522
J Clin Med. 2021 Sep 18;10(18):
pubmed: 34575353
Cell Death Dis. 2020 Oct 30;11(10):934
pubmed: 33127884
J Biol Chem. 2008 May 23;283(21):14177-81
pubmed: 18385130
Chest. 2019 Oct;156(4):774-782
pubmed: 31265835
Iran J Immunol. 2021 Mar;18(1):82-92
pubmed: 33787517
Lancet Respir Med. 2020 Nov;8(11):1154-1158
pubmed: 33131609
Int J Lab Hematol. 2022 Aug;44(4):712-721
pubmed: 35266284
Cell Rep Med. 2021 Mar 16;2(3):100208
pubmed: 33564749
EMBO Mol Med. 2020 Dec 7;12(12):e13001
pubmed: 33078545
Front Immunol. 2021 Aug 31;12:651634
pubmed: 34531847
J Immunol. 1992 Apr 1;148(7):2175-80
pubmed: 1545125
Cell Mol Immunol. 2015 Sep;12(5):633-44
pubmed: 25176527
Cell Immunol. 2005 Jun;235(2):109-16
pubmed: 16171790
Signal Transduct Target Ther. 2020 May 29;5(1):84
pubmed: 32467561
Clin Cancer Res. 2011 Apr 1;17(7):1915-23
pubmed: 21355078
J Infect Dis. 2021 Mar 3;223(5):805-810
pubmed: 33249506
J Clin Med. 2020 Nov 23;9(11):
pubmed: 33238596
J Leukoc Biol. 1998 Aug;64(2):135-46
pubmed: 9715251
Int J Infect Dis. 2021 Jun;107:188-194
pubmed: 33862208
Cells. 2021 Jan 19;10(1):
pubmed: 33477776
Respir Physiol Neurobiol. 2008 Aug 31;162(3):210-5
pubmed: 18674642
J Clin Med Res. 2021 Sep;13(9):474-478
pubmed: 34691321
Nat Rev Immunol. 2018 Feb;18(2):91-104
pubmed: 28990586
Autoimmun Rev. 2020 Jun;19(6):102537
pubmed: 32251717
Life Sci. 2021 May 1;272:119251
pubmed: 33636175
Gene Rep. 2022 Mar;26:101509
pubmed: 35071823
Am J Respir Crit Care Med. 2006 May 1;173(9):1008-15
pubmed: 16456142
Clin Infect Dis. 2021 May 18;72(10):1834-1837
pubmed: 32672790
Ann Intensive Care. 2021 Mar 22;11(1):50
pubmed: 33751264
Mol Immunol. 2021 Oct;138:121-127
pubmed: 34392110
Med Microbiol Immunol. 2021 Dec;210(5-6):283-289
pubmed: 34564742
Immunol Invest. 2022 May;51(4):993-1004
pubmed: 33752550
Cancer Immunol Immunother. 2021 Oct;70(10):2893-2909
pubmed: 33688997
Cell. 2021 Apr 15;184(8):2212-2228.e12
pubmed: 33713620
Front Immunol. 2021 Jul 23;12:719544
pubmed: 34367188
Cell Commun Signal. 2022 Jul 16;20(1):106
pubmed: 35842705
EBioMedicine. 2020 Aug;58:102925
pubmed: 32745993
J Leukoc Biol. 2005 Jul;78(1):80-4
pubmed: 15899982
J Clin Invest. 2003 Mar;111(5):649-58
pubmed: 12618519
Virology. 2009 Sep 1;391(2):265-73
pubmed: 19592063
J Biol Chem. 2013 Nov 29;288(48):34529-44
pubmed: 24121505
Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9331-6
pubmed: 18599457
Am J Respir Crit Care Med. 2020 Sep 15;202(6):812-821
pubmed: 32584597
PLoS Pathog. 2020 Dec 7;16(12):e1009128
pubmed: 33284859
J Exp Med. 2020 Jun 1;217(6):
pubmed: 32302401
Clin Chem Lab Med. 2021 Feb 22;59(7):e289-e292
pubmed: 33606924
Front Immunol. 2020 Jul 10;11:1648
pubmed: 32754159
Nat Rev Cardiol. 2020 Sep;17(9):543-558
pubmed: 32690910
J Immunol. 2006 Feb 1;176(3):1411-20
pubmed: 16424168
Circ Res. 2020 Sep 11;127(7):945-947
pubmed: 32757722
Int J Mol Sci. 2021 Aug 05;22(16):
pubmed: 34445140
Cell Mol Immunol. 2020 Aug;17(8):878-880
pubmed: 32587367
Cell Commun Signal. 2022 Jun 2;20(1):79
pubmed: 35655192

Auteurs

Mohammad Sadegh Soltani-Zangbar (MS)

Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Forough Parhizkar (F)

Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Mojtaba Abdollahi (M)

School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.

Navid Shomali (N)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Leili Aghebati-Maleki (L)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Sima Shahmohammadi Farid (S)

Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Leila Roshangar (L)

Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Ata Mahmoodpoor (A)

Department of Anesthesiology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Mehdi Yousefi (M)

Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. mehdi_yusefi@yahoo.com.
Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. mehdi_yusefi@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH